Somewhat Positive Media Coverage Somewhat Unlikely to Impact Sapiens International (SPNS) Stock Price

News articles about Sapiens International (NASDAQ:SPNS) have trended somewhat positive recently, Accern Sentiment reports. The research firm ranks the sentiment of media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Sapiens International earned a media sentiment score of 0.17 on Accern’s scale. Accern also gave press coverage about the technology company an impact score of 45.3541039354987 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

These are some of the media headlines that may have effected Accern Sentiment’s scoring:

How to Become a New Pot Stock Millionaire

Shares of NASDAQ SPNS traded down $0.33 during midday trading on Tuesday, reaching $8.37. 2,473 shares of the stock were exchanged, compared to its average volume of 38,937. The stock has a market capitalization of $424.61, a price-to-earnings ratio of 31.15, a PEG ratio of 3.92 and a beta of 1.21. Sapiens International has a twelve month low of $8.01 and a twelve month high of $14.30. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.87 and a quick ratio of 1.87.

Sapiens International (NASDAQ:SPNS) last issued its quarterly earnings data on Thursday, March 8th. The technology company reported $0.11 EPS for the quarter, hitting analysts’ consensus estimates of $0.11. Sapiens International had a net margin of 0.13% and a return on equity of 6.81%. The business had revenue of $72.40 million for the quarter, compared to analysts’ expectations of $72.09 million. During the same quarter last year, the company earned $0.12 EPS. The business’s revenue was up 26.8% on a year-over-year basis. analysts anticipate that Sapiens International will post 0.44 earnings per share for the current fiscal year.

SPNS has been the topic of several recent research reports. BidaskClub upgraded shares of Sapiens International from a “sell” rating to a “hold” rating in a report on Friday, March 2nd. William Blair reissued an “outperform” rating on shares of Sapiens International in a research report on Thursday, March 8th. Zacks Investment Research lowered shares of Sapiens International from a “hold” rating to a “sell” rating in a research report on Friday, January 5th. Finally, Barclays lowered shares of Sapiens International from an “overweight” rating to an “equal weight” rating in a research report on Friday, February 16th. One research analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company’s stock. Sapiens International currently has an average rating of “Hold” and an average price target of $15.00.

COPYRIGHT VIOLATION WARNING: “Somewhat Positive Media Coverage Somewhat Unlikely to Impact Sapiens International (SPNS) Stock Price” was reported by Macon Daily and is the sole property of of Macon Daily. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this news story can be viewed at

Sapiens International Company Profile

Sapiens International Corporation N.V. provides software solutions for the insurance and financial services industries in North America, the United Kingdom, other European countries, Israel, and the Asia Pacific. It offers various solutions for life, pension, and annuity providers, including Sapiens ALIS, Sapiens Closed Books, Life Portraits, LifeApply, and LifeSuite.

Insider Buying and Selling by Quarter for Sapiens International (NASDAQ:SPNS)

Receive News & Ratings for Sapiens International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sapiens International and related companies with's FREE daily email newsletter.

Leave a Reply